What the name refers to
A marketed pegylated analogue associated with mechano-growth-factor research, with very limited dependable human evidence.
Evidence and regulatory context
No broadly authorised human medicine is established for this entry. Published evidence may be preclinical, early-stage or sparse, and a research label is not a quality or safety certification.
Reading product records
The record should distinguish a regulated medicine from a research-labelled analogue and state the exact molecule. For injectables, identity and quantity do not replace sterility, endotoxin, storage and batch-traceability information.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.